BDBM50306682 (R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine::3-(2,6-dichloro-3-fluorobenzyloxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine::3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine::CHEMBL601719::CRIZOTINIB::PF-2341066::US10370379, Crizotinib::US10543199, Compound Crizotinib::US10780082, Compound Crizotinib::US11059827, Compound Crizotinib::US11517561, Compound Crizotinib::US12129258, Example Crizotinib::US9126941, PF-2341066::US9199944, Crizotinib::US9226923, Crizotinib
SMILES C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl
InChI Key InChIKey=KTEIFNKAUNYNJU-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 805 hits for monomerid = 50306682
Korea Research Institute of Chemical Technology
US Patent
Tianjin University of Science and Technology
Korea Research Institute of Chemical Technology
US Patent
Korea Research Institute of Chemical Technology
US Patent
Korea Research Institute of Chemical Technology
US Patent
State Key Laboratory of Drug Research
Curated by ChEMBL
Ambit Biosciences
Curated by ChEMBL
Ambit Biosciences
Curated by ChEMBL
Ambit Biosciences
Curated by ChEMBL
State Key Laboratory of Drug Research
Curated by ChEMBL
State Key Laboratory of Drug Research
Curated by ChEMBL
State Key Laboratory of Drug Research
Curated by ChEMBL
